Bringing together leading expertise and state of the art facilities across Western Sydney, the Australian Medicinal Cannabis Research & Education Collaboration (AMCREC) provides a platform for high-quality, independent research, education and consultancy services in medicinal cannabis.
Preclinical in vitro and in vivo models for specific therapeutic applications. Click the link below for more information on techniques or contact us for a quote on analytical testing.
From testing efficacy and safety of products to development of intellectual property and commercialisation of new products. Contact us for a quote on ICH-compliant clinical trials.
PC2 accredited pharmacology laboratories supporting investigations of pharmacokinetics and pharmacodynamics, as well as characterisation of genetic and environmental determinants of constituent profiles.
Product-specific clinical research, including Phase IIa studies exploring the pharmacokinetics and safety elements of medicinal cannabis products within ICH-compliant clinical trial facilities.
Capability to develop medicinal cannabis medicines from ‘bush to bench to bedside’: from early stage cultivation and pharmacognosy, in vitro and in vivo models, through to clinical studies for a go-to-market evidence-based product.
Our collaboration can provide training in medicinal cannabis for authorised prescribers, as well as general education for the public on therapeutic and safety considerations of the medical prescribing of cannabis.
Join us virtually on Thursday 3 September to hear from Australia's leading medicinal cannabis researchers as they discuss their latest findings at the NICM HRI Medicinal Cannabis Research Update 2020 held via Zoom.
The event is free and open to researchers, academics, students and industry with an interest in the developing medicinal cannabis research space. The event will be chaired by AMCREC lead coordinator Justin Sinclar. The full program is available here. Registration for attendance is currently open
Justin Sinclair speaking on cannabis use risk analysis & introducing the Endocannabinoid System